+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Rapid Tests - Global Market Trajectory & Analytics

  • ID: 4805393
  • Report
  • May 2020
  • Region: Global
  • 395 pages
  • Global Industry Analysts, Inc
1 of 2
Amid the COVID-19 crisis and the looming economic recession, the Rapid Tests market worldwide will grow by a projected US$6.9 Billion, during the analysis period, driven by a revised compounded annual growth rate (CAGR) of 6.5%. PCR-based, one of the segments analyzed and sized in this study, is forecast to grow at over 7.4% and reach a market size of US$8.6 Billion by the end of the analysis period. An unusual period in history, the coronavirus pandemic has unleashed a series of unprecedented events affecting every industry. The PCR-based market will be reset to a new normal which going forward in a post COVID-19 era will be continuously redefined and redesigned. Staying on top of trends and accurate analysis is paramount now more than ever to manage uncertainty, change and continuously adapt to new and evolving market conditions.

As part of the new emerging geographic scenario, the United States is forecast to readjust to a 5.1% CAGR. Within Europe, the region worst hit by the pandemic, Germany will add over US$210.3 Million to the region's size over the next 7 to 8 years. In addition, over US$200.5 Million worth of projected demand in the region will come from Rest of the European markets. In Japan, the PCR-based segment will reach a market size of US$357.7 Million by the close of the analysis period. Blamed for the pandemic, significant political and economic challenges confront China. Amid the growing push for decoupling and economic distancing, the changing relationship between China and the rest of the world will influence competition and opportunities in the Rapid Tests market. Against this backdrop and the changing geopolitical, business and consumer sentiments, the world’s second largest economy will grow at 10.8% over the next couple of years and add approximately US$1.8 Billion in terms of addressable market opportunity. Continuous monitoring for emerging signs of a possible new world order post-COVID-19 crisis is a must for aspiring businesses and their astute leaders seeking to find success in the now changing Rapid Tests market landscape. All research viewpoints presented are based on validated engagements from influencers in the market, whose opinions supersede all other research methodologies.

Competitors identified in this market include, among others:

ALS Ltd, AsureQuality Ltd, Bureau Veritas SA, Eurofins Scientific SE, Genetic ID NA, Inc, Intertek Group PLC, Mérieux NutriSciences Corporation, Microbac Laboratories, Inc, Omic USA Inc, Romer Labs, Inc, SGS SA, Tuv Sud AG
Note: Product cover images may vary from those shown
2 of 2
I. INTRODUCTION, METHODOLOGY & REPORT SCOPE

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW
Global Competitor Market Shares
Rapid Test Market (Services) Competitor Market Share Scenario Worldwide (in %): 2019 & 2025
Impact of Covid-19 and a Looming Global Recession

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE

III. MARKET ANALYSIS

GEOGRAPHIC MARKET ANALYSIS

UNITED STATES
Market Facts & Figures
US Rapid Test Market (Services) Market Share (in %) by Company: 2019 & 2025
Market Analytics
CANADA
JAPAN
CHINA
EUROPE
Market Facts & Figures
European Rapid Test Market (Services) Market: Competitor Market Share Scenario (in %)for 2019 & 2025
Market Analytics
FRANCE
GERMANY
ITALY
UNITED KINGDOM
SPAIN
RUSSIA
REST OF EUROPE
ASIA-PACIFIC
AUSTRALIA
INDIA
SOUTH KOREA
REST OF ASIA-PACIFIC
LATIN AMERICA
ARGENTINA
BRAZIL
MEXICO
REST OF LATIN AMERICA
MIDDLE EAST
IRAN
ISRAEL
SAUDI ARABIA
UNITED ARAB EMIRATES
REST OF MIDDLE EAST
AFRICA

IV. COMPETITION
Total Companies Profiled: 38
Note: Product cover images may vary from those shown
3 of 2

Loading
LOADING...

Adroll
adroll